tetano
Editor, Senior Moderator
J Clin Med
. 2021 Feb 19;10(4):849.
doi: 10.3390/jcm10040849.
Immunological Characteristics of Non-Intensive Care Hospitalized COVID-19 Patients: A Preliminary Report
Salvatore Corrao[SUP] 1 2 [/SUP], Francesco Gervasi[SUP] 3 [/SUP], Francesca Di Bernardo[SUP] 4 [/SUP], Giuseppe Natoli[SUP] 1 [/SUP], Massimo Raspanti[SUP] 1 [/SUP], Nicola Catalano[SUP] 1 [/SUP], Christiano Argano[SUP] 1 [/SUP]
Affiliations
Abstract
The outbreak of coronavirus disease 2019 (COVID-19) is posing a threat to global health. This disease has different clinical manifestations and different outcomes. The immune response to the novel 2019 coronavirus is complex and involves both innate and adaptive immunity. In this context, cell-mediated immunity plays a vital role in effective immunity against SARS-CoV-2. Significant differences have been observed when comparing severe and non-severe patients. Since these immunological characteristics have not been fully elucidated, we aimed to use cluster analysis to investigate the immune cell patterns in patients with COVID-19 who required hospitalization but not intensive care. We identified four clusters of different immunological patterns, the worst being characterized by total lymphocytes, T helper lymphocytes CD4[SUP]+[/SUP] (CD4[SUP]+[/SUP]), T cytotoxic lymphocytes CD8[SUP]+[/SUP] (CD8[SUP]+[/SUP]) and natural killer (NK) cells below the normal range, together with natural killer lymphocyte granzyme < 50% (NK granzyme[SUP]+[/SUP]) and antibody-secreting plasma cells (ASCs) equal to 0 with fatal outcomes. In the worst group, 50% of patients died in the intensive care unit. Moreover, a negative trend was found among four groups regarding total lymphocytes, CD4[SUP]+[/SUP], CD8[SUP]+[/SUP] and B lymphocytes (p < 0.001, p < 0.005, p < 0.000, p < 0.044, respectively). This detailed analysis of immune changes may have prognostic value. It may provide a new perspective for identifying subsets of COVID-19 patients and selecting novel prospective treatment strategies. Notwithstanding these results, this is a preliminary report with a small sample size, and our data may not be generalizable. Further cohort studies with larger samples are necessary to quantify the prognostic value's weight, according to immunological changes in COVID-19 patients, for predicting prognoses and realizing improvements in clinical conditions.
Keywords: SARS-CoV-2; cluster analysis; immune system deficiency; multiparametric flow cytometry.
. 2021 Feb 19;10(4):849.
doi: 10.3390/jcm10040849.
Immunological Characteristics of Non-Intensive Care Hospitalized COVID-19 Patients: A Preliminary Report
Salvatore Corrao[SUP] 1 2 [/SUP], Francesco Gervasi[SUP] 3 [/SUP], Francesca Di Bernardo[SUP] 4 [/SUP], Giuseppe Natoli[SUP] 1 [/SUP], Massimo Raspanti[SUP] 1 [/SUP], Nicola Catalano[SUP] 1 [/SUP], Christiano Argano[SUP] 1 [/SUP]
Affiliations
- PMID: 33669527
- DOI: 10.3390/jcm10040849
Abstract
The outbreak of coronavirus disease 2019 (COVID-19) is posing a threat to global health. This disease has different clinical manifestations and different outcomes. The immune response to the novel 2019 coronavirus is complex and involves both innate and adaptive immunity. In this context, cell-mediated immunity plays a vital role in effective immunity against SARS-CoV-2. Significant differences have been observed when comparing severe and non-severe patients. Since these immunological characteristics have not been fully elucidated, we aimed to use cluster analysis to investigate the immune cell patterns in patients with COVID-19 who required hospitalization but not intensive care. We identified four clusters of different immunological patterns, the worst being characterized by total lymphocytes, T helper lymphocytes CD4[SUP]+[/SUP] (CD4[SUP]+[/SUP]), T cytotoxic lymphocytes CD8[SUP]+[/SUP] (CD8[SUP]+[/SUP]) and natural killer (NK) cells below the normal range, together with natural killer lymphocyte granzyme < 50% (NK granzyme[SUP]+[/SUP]) and antibody-secreting plasma cells (ASCs) equal to 0 with fatal outcomes. In the worst group, 50% of patients died in the intensive care unit. Moreover, a negative trend was found among four groups regarding total lymphocytes, CD4[SUP]+[/SUP], CD8[SUP]+[/SUP] and B lymphocytes (p < 0.001, p < 0.005, p < 0.000, p < 0.044, respectively). This detailed analysis of immune changes may have prognostic value. It may provide a new perspective for identifying subsets of COVID-19 patients and selecting novel prospective treatment strategies. Notwithstanding these results, this is a preliminary report with a small sample size, and our data may not be generalizable. Further cohort studies with larger samples are necessary to quantify the prognostic value's weight, according to immunological changes in COVID-19 patients, for predicting prognoses and realizing improvements in clinical conditions.
Keywords: SARS-CoV-2; cluster analysis; immune system deficiency; multiparametric flow cytometry.